Related Experiment Video
Updated: Jun 26, 2026
09:52
Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
Published on: January 25, 2015
Hepatoma occurring two decades after hepatic irradiation
Gastroenterology
|July 1, 1976
Summary
Therapeutic hepatic irradiation, previously unlinked to hepatoma, may contribute to liver cancer development. This case study highlights a potential link between radiation and hepatocellular carcinoma decades after treatment.
Area of Science:
- Hepatology
- Oncology
- Radiation Oncology
Background:
- Hepatoma (liver cancer) is linked to various factors including chemical, dietary, metabolic, infectious, and genetic influences.
- Therapeutic hepatic irradiation has not been previously associated with the development of hepatoma.
- Radiation-related liver disease encompasses a range of conditions affecting the liver following radiation exposure.
Observation:
- A case of hepatocellular carcinoma (HCC) is presented.
- The HCC diagnosis occurred two decades after the patient received radiotherapy.
- The initial radiotherapy was for a presumed hepatic hemangioma.
Findings:
- This case suggests a potential association between prior therapeutic hepatic irradiation and the subsequent development of hepatocellular carcinoma.
- The latency period of two decades indicates a long-term effect of radiation on liver carcinogenesis.
- Radiation hepatocarcinogenesis, the process by which radiation induces cancer in the liver, is a key focus.
Implications:
- This finding warrants further investigation into the long-term risks of hepatic irradiation.
- Understanding radiation hepatocarcinogenesis is crucial for refining radiation therapy protocols and patient monitoring.
- Clinical vigilance for secondary malignancies in patients treated with hepatic radiotherapy is recommended.
